Does gabapentin cause you to gain weight
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Weight Gain: An Analysis of Current Research
Introduction to Gabapentin and Weight Gain
Gabapentin, an anticonvulsant medication, is widely used for treating conditions such as epilepsy and neuropathic pain. However, one of the concerns associated with its use is the potential for weight gain. This article synthesizes findings from multiple studies to provide a clear understanding of whether gabapentin causes weight gain.
Evidence from Long-Term Gabapentin Therapy
Chronic High-Dose Gabapentin and Weight Changes
A study involving 44 patients treated with high-dose gabapentin (GPN) for over 12 months revealed significant weight changes. Approximately 25 patients experienced weight gain, with 10 patients gaining more than 10% of their baseline weight and 15 patients gaining between 5% to 10% of their baseline weight. Weight gain typically began between the second and third months of treatment and stabilized after 6 to 9 months, even though the dosage remained unchanged .
Gabapentin Enacarbil (GEn) and Weight Gain in Diabetic Neuropathy
In a phase 2 trial examining gabapentin enacarbil (GEn), a prodrug of gabapentin, patients with painful diabetic peripheral neuropathy (DPN) showed varying incidences of weight gain. The study found that weight gain was dose-dependent, with higher doses of GEn (3600 mg/day) resulting in more significant weight gain compared to lower doses (1200 mg/day). However, the weight gain associated with GEn was generally lower than that observed with pregabalin, another medication used for similar conditions 23.
Comparative Studies and Meta-Analyses
Systematic Review and Meta-Analysis
A comprehensive systematic review and meta-analysis of 257 randomized trials, including gabapentin, indicated that gabapentin is associated with an average weight gain of 2.2 kg. This finding places gabapentin among several other drugs known to cause weight gain, such as amitriptyline and olanzapine .
Long-Term Safety and Weight Gain
In a study focusing on the long-term safety of a gastroretentive formulation of gabapentin (G-GR) in patients with postherpetic neuralgia (PHN), the mean weight change over a 24-week period was relatively modest at +0.76 kg. Only 2.5% of patients reported weight gain as an adverse event, suggesting that long-term treatment with G-GR is associated with minimal weight gain .
Clinical Observations and Patient Reports
Observational Data from Clinical Settings
Clinical observations from epilepsy clinics have noted weight gain in patients treated with gabapentin. In a review of 69 patients, the mean weight gain was 6.9 kg, with the weight gain being more pronounced in patients on higher doses of gabapentin. This suggests that weight gain may be more significant in real-world settings compared to controlled clinical trials .
Conclusion
The evidence indicates that gabapentin can cause weight gain, particularly at higher doses and with long-term use. The extent of weight gain varies among individuals and appears to be dose-dependent. While some studies report modest weight increases, others highlight more significant gains, especially in clinical practice. Patients and healthcare providers should be aware of this potential side effect and monitor weight changes during gabapentin therapy.
Sources and full results
Most relevant research papers on this topic